SCHEMBL29518372

SCHEMBL29518372

FC(F)Oc1ccc(OC(F)F)c(Br)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.43
GFER P55789 1/20 0.43
ADAM17 P78536 1/20 0.43
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 6/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PKM P14618 2/20 0.38
POLB P06746 4/20 0.38
TDP1 Q9NUW8 3/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 5/20 0.36
DRD1 P21728 1/20 0.36
PPARA Q07869 1/20 0.36
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20560951 1.00 ALOX15 (0.43) ALOX15GFERADAM17MEN1KMT2A
SCHEMBL8163306 0.85 GPR3 (0.41) ALOX15LMNANPC1RAB9ASMN1; SMN2
SCHEMBL25368387 0.83 ALOX15 (0.43) ALOX15GFERADAM17MEN1KMT2A
SCHEMBL17175976 0.79 THRA (0.40) MEN1KMT2ALMNASMN1; SMN2HTT
SCHEMBL15016881 0.79 ALOX15 (0.43) ALOX15GFERADAM17MEN1KMT2A
SCHEMBL30599536 0.79 PKM (0.47) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL29888754 0.79 ALOX15 (0.43) ALOX15GFERADAM17MEN1KMT2A
SCHEMBL1438674 0.79 PKM (0.47) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL20562225 0.79 MEN1 (0.43) ALOX15GFERADAM17MEN1KMT2A
SCHEMBL30571340 0.79 MEN1 (0.43) ALOX15GFERADAM17MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114026096-B Tetrazole-substituted pyrazolopyrimidine JAK kinase inhibitor and application thereof 豪夫迈·罗氏有限公司 2025-02-07 CN disclosed
CN-110650959-B Therapeutic compounds and compositions and methods of use thereof 豪夫迈·罗氏有限公司 2023-04-18 CN disclosed
EP-3986900-A1 TETRAZOLE-SUBSTITUTED PYRAZOLOPYRIMIDINE INHIBITORS OF JAK KINASES AND USES THEREOF F. Hoffmann-La Roche AG (CH) 2022-04-27 EP disclosed